Close

St. Jude Medical, Inc. (STJ) Reports Positive Prelim. EnligHTN III Results

May 22, 2014 6:19 AM EDT Send to a Friend
St. Jude Medical, Inc. (NYSE: STJ) announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN™ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login